Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Assets (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Assets for 3 consecutive years, with $412.7 million as the latest value for Q4 2025.

  • Quarterly Assets rose 28.63% to $412.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $412.7 million through Dec 2025, up 28.63% year-over-year, with the annual reading at $412.7 million for FY2025, 28.63% up from the prior year.
  • Assets hit $412.7 million in Q4 2025 for Guardian Pharmacy Services, up from $390.0 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $412.7 million in Q4 2025 to a low of $271.2 million in Q4 2023.
  • Historically, Assets has averaged $347.6 million across 3 years, with a median of $348.0 million in 2024.
  • Biggest YoY gain for Assets was 28.63% in 2025; the steepest drop was 12.07% in 2025.
  • Year by year, Assets stood at $271.2 million in 2023, then rose by 18.31% to $320.8 million in 2024, then rose by 28.63% to $412.7 million in 2025.
  • Business Quant data shows Assets for GRDN at $412.7 million in Q4 2025, $390.0 million in Q3 2025, and $356.3 million in Q2 2025.